Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.

Immunotherapy using regulatory T cells (Treg) has been proposed, yet cellular and molecular mechanisms of human Tregs remain incompletely characterized. Here, we demonstrate that human Tregs promote the generation of myeloid dendritic cells (DC) with reduced capacity to stimulate effector T cell res...

Full description

Bibliographic Details
Main Authors: Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, Jessica L Ullman, William G Telford, Veena Kapoor, James L Riley, Bruce L Levine, Carl H June, Timothy Fong, Noel L Warner, Daniel H Fowler
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-02-01
Series:PLoS Biology
Online Access:http://europepmc.org/articles/PMC2814822?pdf=render
_version_ 1818690165685616640
author Shoba Amarnath
Carliann M Costanzo
Jacopo Mariotti
Jessica L Ullman
William G Telford
Veena Kapoor
James L Riley
Bruce L Levine
Carl H June
Timothy Fong
Noel L Warner
Daniel H Fowler
author_facet Shoba Amarnath
Carliann M Costanzo
Jacopo Mariotti
Jessica L Ullman
William G Telford
Veena Kapoor
James L Riley
Bruce L Levine
Carl H June
Timothy Fong
Noel L Warner
Daniel H Fowler
author_sort Shoba Amarnath
collection DOAJ
description Immunotherapy using regulatory T cells (Treg) has been proposed, yet cellular and molecular mechanisms of human Tregs remain incompletely characterized. Here, we demonstrate that human Tregs promote the generation of myeloid dendritic cells (DC) with reduced capacity to stimulate effector T cell responses. In a model of xenogeneic graft-versus-host disease (GVHD), allogeneic human DC conditioned with Tregs suppressed human T cell activation and completely abrogated posttransplant lethality. Tregs induced programmed death ligand-1 (PD-L1) expression on Treg-conditioned DC; subsequently, Treg-conditioned DC induced PD-L1 expression in vivo on effector T cells. PD-L1 blockade reversed Treg-conditioned DC function in vitro and in vivo, thereby demonstrating that human Tregs can promote immune suppression via DC modulation through PD-L1 up-regulation. This identification of a human Treg downstream cellular effector (DC) and molecular mechanism (PD-L1) will facilitate the rational design of clinical trials to modulate alloreactivity.
first_indexed 2024-12-17T12:21:40Z
format Article
id doaj.art-51447135cf054e8d9db8f38373ff2954
institution Directory Open Access Journal
issn 1544-9173
1545-7885
language English
last_indexed 2024-12-17T12:21:40Z
publishDate 2010-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Biology
spelling doaj.art-51447135cf054e8d9db8f38373ff29542022-12-21T21:48:57ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852010-02-0182e100030210.1371/journal.pbio.1000302Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.Shoba AmarnathCarliann M CostanzoJacopo MariottiJessica L UllmanWilliam G TelfordVeena KapoorJames L RileyBruce L LevineCarl H JuneTimothy FongNoel L WarnerDaniel H FowlerImmunotherapy using regulatory T cells (Treg) has been proposed, yet cellular and molecular mechanisms of human Tregs remain incompletely characterized. Here, we demonstrate that human Tregs promote the generation of myeloid dendritic cells (DC) with reduced capacity to stimulate effector T cell responses. In a model of xenogeneic graft-versus-host disease (GVHD), allogeneic human DC conditioned with Tregs suppressed human T cell activation and completely abrogated posttransplant lethality. Tregs induced programmed death ligand-1 (PD-L1) expression on Treg-conditioned DC; subsequently, Treg-conditioned DC induced PD-L1 expression in vivo on effector T cells. PD-L1 blockade reversed Treg-conditioned DC function in vitro and in vivo, thereby demonstrating that human Tregs can promote immune suppression via DC modulation through PD-L1 up-regulation. This identification of a human Treg downstream cellular effector (DC) and molecular mechanism (PD-L1) will facilitate the rational design of clinical trials to modulate alloreactivity.http://europepmc.org/articles/PMC2814822?pdf=render
spellingShingle Shoba Amarnath
Carliann M Costanzo
Jacopo Mariotti
Jessica L Ullman
William G Telford
Veena Kapoor
James L Riley
Bruce L Levine
Carl H June
Timothy Fong
Noel L Warner
Daniel H Fowler
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.
PLoS Biology
title Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.
title_full Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.
title_fullStr Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.
title_full_unstemmed Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.
title_short Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.
title_sort regulatory t cells and human myeloid dendritic cells promote tolerance via programmed death ligand 1
url http://europepmc.org/articles/PMC2814822?pdf=render
work_keys_str_mv AT shobaamarnath regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT carliannmcostanzo regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT jacopomariotti regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT jessicalullman regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT williamgtelford regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT veenakapoor regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT jameslriley regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT brucellevine regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT carlhjune regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT timothyfong regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT noellwarner regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1
AT danielhfowler regulatorytcellsandhumanmyeloiddendriticcellspromotetoleranceviaprogrammeddeathligand1